Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice

Early life exposure to antidepressants frequently occurs when pregnant mothers take the medication during late pregnancy. Previous studies in animal models have shown that early exposure to certain antidepressants can alter some behaviors in adulthood. We examined whether the administration of clomipramine, a serotonin reuptake inhibitor, to neonatal mice could result in depression-related behavioral alterations in adult mice. In addition, in an attempt to uncover the mechanism underlying these behavioral changes, we examined the expression of candidate genes in different areas of the brain. Here we show that mice chronically injected with clomipramine specifically during early postnatal development demonstrated depression-like behavior as well as altered stress responses in adulthood. An analysis of the expression of serotonergic genes after exposure to social defeat stress revealed small but significant changes in the expression of 5-HT1A receptor gene (Htr1a) and 5-HTT gene (Slc6a4) in the mice treated with clomipramine compared with the mice injected with saline. We concluded that antidepressant exposure in early days of life could alter stress-related behavior in adulthood and that the behavioral alterations are accompanied by altered serotonergic gene expressions.

[1]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[2]  L. Christiansen,et al.  Candidate Gene Polymorphisms in the Serotonergic Pathway: Influence on Depression Symptomatology in an Elderly Population , 2007, Biological Psychiatry.

[3]  M. Ansorge,et al.  Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice , 2008, The Journal of Neuroscience.

[4]  G. Vogel,et al.  Diminished sexual activity in a new animal model of endogenous depression , 1990, Neuroscience & Biobehavioral Reviews.

[5]  I. Paul,et al.  Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry , 2006, Neuropsychopharmacology.

[6]  Rachel A. Millstein,et al.  Early life genetic, epigenetic and environmental factors shaping emotionality in rodents , 2005, Neuroscience & Biobehavioral Reviews.

[7]  R. Hen,et al.  Behavioral / Systems / Cognitive Serotonin-1 A Autoreceptors Are Necessary and Sufficient for the Normal Formation of Circuits Underlying Innate Anxiety , 2011 .

[8]  D. Murphy,et al.  Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression , 2003, Biological Psychiatry.

[9]  R. Hen,et al.  Neurodevelopmental origins of depressive disorders. , 2007, Current opinion in pharmacology.

[10]  T. Ohmori,et al.  Molecular assessment of depression from mRNAs in the peripheral leukocytes , 2008, Annals of medicine.

[11]  E. Fuchs,et al.  Social stress in tree shrews Effects on physiology, brain function, and behavior of subordinate individuals , 2002, Pharmacology Biochemistry and Behavior.

[12]  L. Maffei,et al.  The Antidepressant Fluoxetine Restores Plasticity in the Adult Visual Cortex , 2008, Science.

[13]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[14]  David A Lewis,et al.  A molecular signature of depression in the amygdala. , 2009, The American journal of psychiatry.

[15]  M. Toth,et al.  Paradoxical anxiogenic response of juvenile mice to fluoxetine , 2009, Neuropsychopharmacology.

[16]  M. Ansorge,et al.  New Lessons From Knockout Mice: The Role of Serotonin During Development and Its Possible Contribution to the Origins of Neuropsychiatric Disorders , 2003, CNS Spectrums.

[17]  S. Hansson,et al.  Serotonin transporter messenger RNA in the developing rat brain: early expression in serotonergic neurons and transient expression in non-serotonergic neurons , 1998, Neuroscience.

[18]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[19]  A. Armario,et al.  The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat , 1998, Psychopharmacology.

[20]  L. Maffei,et al.  Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats , 2011, The European journal of neuroscience.

[21]  René Hen,et al.  5-HT1A Autoreceptor Levels Determine Vulnerability to Stress and Response to Antidepressants , 2010, Neuron.

[22]  J. Velázquez-Moctezuma,et al.  Neonatal treatment with clomipramine increased immobility in the forced swim test: An attribute of animal models of depression , 1992, Pharmacology Biochemistry and Behavior.

[23]  I. Ferrier,et al.  5HT2 receptor changes in major depression , 1990, Biological Psychiatry.

[24]  M. Corner,et al.  Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: Effects upon adult sleep and behavior in the rat , 1981, Brain Research.

[25]  S. Andersen,et al.  A Novel, Multiple Symptom Model of Obsessive-Compulsive-Like Behaviors in Animals , 2010, Biological Psychiatry.

[26]  V. Arango,et al.  Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice , 2003, Biological Psychiatry.

[27]  F. Holsboer,et al.  Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine , 2008, Psychopharmacology.

[28]  J. Velázquez-Moctezuma,et al.  Corticosterone and Testosterone Levels after Chronic Stress in an Animal Model of Depression , 2003, Neuropsychobiology.

[29]  J. Neumaier,et al.  Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder , 2011, Psychopharmacology.

[30]  C. Hertzman,et al.  Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. , 2006, Archives of general psychiatry.

[31]  C. Nemeroff,et al.  Neurobiological and psychiatric consequences of child abuse and neglect. , 2010, Developmental psychobiology.

[32]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[33]  G. Vogel,et al.  A new animal model of endogenous depression: A summary of present findings , 1990, Neuroscience & Biobehavioral Reviews.

[34]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[35]  James C. Overholser,et al.  Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder , 2007, The Journal of Neuroscience.

[36]  Guanghua Xiao,et al.  Imipramine Treatment and Resiliency Exhibit Similar Chromatin Regulation in the Mouse Nucleus Accumbens in Depression Models , 2009, The Journal of Neuroscience.

[37]  D. Mehta,et al.  Gene Expression Studies in Major Depression , 2010, Current psychiatry reports.

[38]  F. Lynch,et al.  Trends in the prescribing of psychotropic medications to preschoolers. , 2000, JAMA.

[39]  D. Murphy,et al.  Abnormal anxiety‐related behavior in serotonin transporter null mutant mice: the influence of genetic background , 2003, Genes, brain, and behavior.

[40]  C. Benkelfat,et al.  Patterns of gene expression in the limbic system of suicides with and without major depression , 2007, Molecular Psychiatry.

[41]  W. Gilmer,et al.  Early experience and depressive disorders: human and non-human primate studies. , 2003, Journal of affective disorders.

[42]  T. Oberlander,et al.  Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical Evidence , 2009, Clinical pharmacology and therapeutics.

[43]  B. Carroll,et al.  Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. , 2006, JAMA.

[44]  H. Anisman,et al.  Sex differences in hormonal responses to a social stressor in chronic major depression , 2009, Psychoneuroendocrinology.

[45]  C. Swanson,et al.  Efficacy of the MCHR1 Antagonist N-[3-(1-{[4-(3,4-Difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in Mouse Models of Anxiety and Depression following Acute and Chronic Administration Is Independent of Hippocampal Neurogenesis , 2007, Journal of Pharmacology and Experimental Therapeutics.